要精准应用经导管技术治疗高血压
颜红兵,郭静萱,霍勇
摘要(Abstract):
<正>高血压的非药物治疗已有近九十年的历史,先后出现了交感神经切除术、人工髂动-静脉造瘘、颈动脉压力感受器刺激、颈动脉体消融、脑神经深度刺激、持续气道正压通气和经导管治疗等众多技术~([1-3])。经导管治疗技术主要包括经导管去肾交感神经(renaldenervation,RDN)、肾动脉血运重建和肾上腺消融。
关键词(KeyWords): 经导管去肾交感神经;高血压;动脉粥样硬化
基金项目(Foundation):
作者(Author): 颜红兵,郭静萱,霍勇
参考文献(References):
- [1] Harris SH. Renal sympathectomy:its scope and limitations:(Section of Urology)[J]. Proc R Soc Med, 1935, 28(11):1497-1510.
- [2] Mahfoud F, Schlaich MP, Lobo MD. Device therapy of hypertension[J]. Circ Res, 2021, 128(7):1080-1099.
- [3] Lohmeier TE, Hall JE. Device-based neuromodulation for resistant hypertension therapy[J]. Circ Res, 2019, 124(7):1071-1093.
- [4] Yamamoto E, Sueta D, Tsujita K. Renal denervation in resistant hypertension:a review of clinical trials and future perspectives[J]. Cardiovasc Interv Ther, 2022, 37(3):450-457.
- [5]刘健,王岚,孙浩宁.经导管去肾交感神经术治疗高血压:现状[J].中国介入心脏病学杂志,2022,30(7):499-502.
- [6] Li P, Liu B, Wu X, et al. Perirenal adipose af ferent nerves sustain pathological high blood pressure in rats[J]. Nat Commun, 2022, 13(1):3130.
- [7] Ji M, Chen H, Shen L, et al. Validation of a novel renal denervation system with cryoablation:a preclinical study and case series[J]. JACC Basic Transl Sci, 2022, 7(2):101-112.
- [8] Manaktala R, Tafur-Soto JD, White CJ. Renal artery stenosis in the patient with hypertension:prevalence, impact and management[J]. Integr Blood Press Control, 2020, 13:71-82.
- [9]牛国晨,闫子光,张碧辉,等.肾动脉狭窄血管腔内成形术治疗高血压:现状与展望[J].中国介入心脏病学杂志,2022,30(7):513-517.
- [10] Rossi GP, Bisogni V, Bacca AV, et al. The 2020 Italian Society of Arterial Hypertension(SIIA)practical guidelines for the management of primary aldosteronism[J]. Int J Cardiol Hypertens, 2020, 5:100029.
- [11]祝之明.经导管肾上腺消融术治疗原发性醛固酮增多症相关高血压:现状与展望[J].中国介入心脏病学杂志,2022,30(7):503-507.
- [12]曾正陪,陈康.肾上腺消融术治疗原发性醛固酮增多症应慎重开展:内分泌科观点[J].中国介入心脏病学杂志,2022,30(7):508-512.
- [13] Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease[J]. Hypertension, 2020, 75(2):285-292.
- [14]张宇清,苗欢欢,杨世杰,等.谋定后动——新近高血压重要研究中的启示[J].中国介入心脏病学杂志,2022,30(7):518-521.
- [15] Acelajado MC, Hughes ZH, Oparil S, et al. Treatment of resistant and refractory hypertension[J]. Circ Res, 2019,124(7):1061-1070.
- [16] Bourque G, Hiremath S. Rethinking resistant hypertension[J].J Clin Med, 2022, 11(5):1455.